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A Mutation in the Stalk of the Newcastle Disease Virus
Hemagglutinin-Neuraminidase (HN) Protein Prevents Triggering of
the F Protein despite Allowing Efficient HN-F Complex Formation
Anne M. Mirza, Ronald M. Iorio
Department of Microbiology and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester,
Massachusetts, USA
Newcastle disease virus (NDV)-inducedmembrane fusion requires formation of a complex between the hemagglutinin-neur-
aminidase (HN) and fusion (F) proteins. Substitutions for NDVHN stalk residues A89, L90, and L94 block fusion by modulating
formation of the HN-F complex. Here, we demonstrate that a nearby L97A substitution, though previously shown to block fu-
sion, allows efficient HN-F complex formation and likely acts by preventing changes in the HN stalk required for triggering of
the bound F protein.
Newcastle disease virus (NDV) is a member of the negative-stranded, RNA-containing Paramyxoviridae (1). Similar to
most paramyxoviruses, NDV-induced membrane fusion requires
an interaction between the hemagglutinin-neuraminidase (HN)
attachment and fusion (F) proteins (1).
The ectodomain of HN consists of a stalk supporting a termi-
nal globular head (1). Whereas the globular domain mediates
binding to sialic acid receptors, catalyzes neuraminidase activity
(NA), and contains all the antigenic sites (2, 3), the stalk mediates
the F interaction (4–7). Mutations in NDV HN stalk residues A89,
L90, and L94 specifically modulate fusion with no effect on
hemadsorption (HAd), NA, or antigenic structure (8). For these
mutations, the extent of fusion correlates directly with the amount
of the HN-F complex detectable at the cell surface (9), consistent
with these residues contributing to the F interaction. This is sup-
ported by the surface exposure of all three residues in the crystal
structure of the tetrameric NDV HN ectodomain (10).
However, in this structure these residues appear to be shielded
from contacting F by the base of the globular head. This has led to
the hypothesis that receptor binding may induce a conformational
change that shifts the heads up to expose the F-interactive domain
(11). This is consistent with the idea, based on ER retention (12)
and attachment-deficient mutants (13), that HN does not interact
with F until triggered to do so by receptor binding (9), though
evidence to the contrary has recently been published (14).
Whereas the F protein must undergo a dramatic conforma-
tional rearrangement to trigger fusion (1), it is difficult to envision
this taking place while F is still HN bound, suggesting that the
HN-F complex may be transient. We sought to identify HN stalk
mutations that would allow formation of the complex, but block
fusion triggering, reasoning that such mutations might make it
possible to capture an intermediate in the fusion-triggering cas-
cade, which could serve as a reagent to probe the structure of the
complex.
HN stalk residues R83 and L97 are also surface exposed (10)
and R83N and L97A mutations also specifically inhibit fusion (15,
16). Although the fusion deficiency of R83N-mutated HN corre-
lated with loss of the ability of the protein to interact with F (16),
the F-interactive capability of L97A-mutated HN was not previ-
ously determined. Thus, we have characterized the effect of A and
T substitutions for residues R83 and L97. Also, reasoning that the
triggering cascade is transmitted from the receptor binding site in
the head to the F-interactive domain in the stalk, we have deter-
mined the effect of alanine substitutions for additional residues
immediately membrane-distal to L97 for their effect on HN func-
tion. A95R and -S substitutions were previously shown to have
little or no effect on fusion (8), and an L96A-mutated protein
retained about 1/3 of wild-type (wt) activity (15). Therefore, these
residues were not investigated.
Using NDV HN in pBluescript SK() (Stratagene Cloning
Systems, La Jolla, CA) and the QuikChange site-directed mu-
tagenesis kit (Stratagene, La Jolla, CA), we prepared HN mu-
tants with substitutions of R83A or -T, L97A or -T, N98A,
T99A, or E100A. The presence of each mutation was confirmed
by sequencing.
Wild-type and mutated HN proteins were expressed in BHK-
21F cells, using the vaccinia virus-T7 RNA polymerase expression
system (17). Cells were seeded in six-well plates at 4  105 cells/
well 1 day prior to transfection and assays were performed at 24 h
posttransfection. Cell surface expression (CSE) was determined
by the University of Massachusetts Medical School Flow Cytom-
etry Laboratory, using a mixture of conformational HN-specific
monoclonal antibodies (MAbs) (18–21). Receptor binding and
NA were determined, respectively, by HAd of guinea pig erythro-
cytes (Bio-Link Laboratories, Liverpool, NY) (8) and cleavage of
2-(4-methylumbelliferyl)--D-N-acetylneuraminic acid (MUN)
(22). Fusion was quantitated using a content-mixing assay (8).
Each of the mutated proteins is expressed at the cell surface at
levels ranging from 71 to 109% of wt (Fig. 1A). HAd activity at 4°C
was only minimally affected, with levels ranging from 79 to 109%
of wt (Fig. 1B). Although NA was diminished for E100A-mutated
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HN (33% of wt), each of the other mutants exhibited60% of wt
activity (Fig. 1B).
Despite the lack of a significant modulation of CSE, HAd, or
NA, several of the mutated proteins were markedly diminished in
the ability to trigger fusion (Fig. 1C and Fig. 2). While R83A-
mutated HN promotes approximately 20% of wt fusion, the
R83T, L97A, and L97T proteins all promote fusion at6% of the
level of wt HN. The phenotype of the L97A protein is similar to
that reported previously (15), though at that time fusion was re-
ported as 18% of wt, as determined by counting nuclei in syncytia
in Cos-7 cells. The A mutations of residues N98, T99, and E100 all
promoted significant levels of fusion (Fig. 1C and Fig. 2) and were
not considered further.
Since the fusion deficiency resulting from dimer interface mu-
tations in the globular domain correlates with an apparent disrup-
tion of a second sialic acid binding site, detectable by unstable
HAd at 37°C (23), we also measured HAd at this temperature. For
all the fusion-deficient mutants, HAd relative to that of the wt
protein was actually more efficient at the higher temperature than
it was in the cold (data not shown). Thus, we conclude that the
diminished fusion promoted by these mutants is not due to an
effect on either sialic acid binding site.
Having confirmed that three additional amino acid substitu-
tions, R83T, L97A, and L97T, result in a specific decrease in fu-
sion, we next determined the ability of the mutated proteins to
take part in the complex with F. This was accomplished using a cell
surface coimmunoprecipitation (co-IP)-Western blot assay (23).
Briefly, wt or mutated HN was coexpressed on the surfaces of
BHK-21F cells with a cleavage site mutant form of F (csmF), sur-
face proteins were biotinylated, the cells were lysed, and HN was
immunoprecipitated through its interaction with csmF using an
F-specific MAb and detected by Western blotting using an MAb to
a linear epitope in HN (21).
Figure 3 shows that the R83T substitution also markedly di-
minishes the ability of HN to interact with F (Fig. 3). The amount
of co-IP is comparable to that of the negative control, A89Q-
mutated HN (8). L97T-mutated HN coimmunoprecipitates more
efficiently than either of these mutated proteins but still at a lower
level than wt HN. However, L97A-mutated HN interacts with the
F protein to an extent comparable to that of wt HN (Fig. 3). Effi-
cient expression of HN and F was verified in each sample (Fig. 3).
Taken together, these findings indicate that L97A-mutated HN
associates efficiently with F but does not trigger it to promote
FIG 1 Functional characterization of HN stalk mutants. CSE (A), HAd (4°C)
and NA (B), and fusion-promoting activity (C) were determined for each of
the mutants. Data were corrected for background obtained with vector alone
and normalized to the value obtained with wt HN, which was set at 100%.
Averages  standard deviations from three independent experiments are
shown.
FIG 2 Syncytium formation in monolayers coexpressing wt HN or HN stalk
mutants and the wt NDV F protein. The extent of syncytium formation is
shown in monolayers expressing wt F with vector control (vec), wt HN, or HN
carrying a R83A, R83T, L97A, L97T, N98A, T99A, or E100A mutation. Mono-
layers were fixed with methanol and stained with Giemsa.
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fusion. Thus, the mutation blocks a step in the fusion cascade
subsequent to HN-F complex formation and may act by prevent-
ing the rearrangements in HN necessary for fusion triggering. This
mutation is analogous to the I98A mutation in the stalk of the
measles virus (MV) hemagglutinin (H), which also blocks fusion
triggering and increases the avidity of the H-F complex (24, 25).
This is significant, as it is thought that while the MV H-F complex
forms intracellularly prior to receptor binding, the NDV HN-F
complex appears to initially form at the cell surface upon receptor
binding (reviewed in reference 9). The identification of a trigger
that acts similarly in both viral attachment proteins indicates a
commonality in paramyxovirus fusion triggering models in the
two viruses and is consistent with the stalk domains of both MV H
and NDV HN playing an active role in fusion triggering.
Finally, whereas L97A-mutated NDV HN appears to allow
HN-F complex formation but prevents the complex dissociation
that would presumably be integral to fusion triggering, it may
make it possible to capture an intermediate in the fusion-trigger-
ing cascade that could be useful in understanding the structure of
the HN-F complex.
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FIG3 Ability of the HN stalk mutants to interact with csmF. (Top) Amount of
HN brought down in a cell surface co-IP with antibody to the F protein, as
detected by a biotinylated co-IP-Western blot assay. The negative control
A89Q-mutated HN interacts with csmF only weakly (8). Total cell surface HN
(middle) and csmF (bottom) are also shown.
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